INTRODUCTION: Reported increases in surgical wait times for cancer have intensified the focus on this quality of health care indicator and have created a very public, concerted effort by providers to decrease wait times for cancer surgery in Ontario. Delays in access to health care are multifactorial and their measurement from existing administrative databases can lack pertinent detail. The purpose of our study was to use a real-time surgery-booking software program to examine surgical wait times at a single centre. METHODS: The real-time wait list management system Axcess.Rx has been used exclusively by the department of urology at the Kingston General Hospital to book all nonemergency surgery for 4 years. We reviewed the length of time from the decision to perform surgery to the actual date of surgery for patients in our group urological practice. Variables thought to be potentially important in predicting wait time were also collected, including the surgeon's assessment of urgency, the type of procedure (i.e., diagnostic, minor cancer, major cancer, minor benign, major benign), age and sex of the patient, inpatient versus outpatient status and year of surgery. Analysis was planned a priori to determine factors that affected wait time by using multivariate analysis to analyze variables that were significant in univariate analysis. RESULTS: There were 960 operations for cancer and 1654 for benign conditions performed during the evaluation period. The overall mean wait time was 36 days for cancer and 47 days for benign conditions, respectively. The mean wait time for cancer surgery reached a nadir in 2004 at 29.9 days and subsequently increased every year, reaching 56 days in 2007. In comparison, benign surgery reached a nadir wait time of 33.7 days in 2004 and in 2007 reached 74 days at our institution. Multivariate analysis revealed that the year of surgery was still a significant predictor of wait time. Urgency score, type of procedure and inpatient versus outpatient status were also predictive of wait time. CONCLUSION: The application of a prospectively collected data set is an effective and important tool to measure and subsequently examine surgical wait times. This tool has been essential to the accurate assessment of the effect of resource allocation on wait times for priority and nonpriority surgical programs within a discipline. Such tools are necessary to more fully assess and follow wait times at an institution or across a region.
INTRODUCTION: Reported increases in surgical wait times for cancer have intensified the focus on this quality of health care indicator and have created a very public, concerted effort by providers to decrease wait times for cancer surgery in Ontario. Delays in access to health care are multifactorial and their measurement from existing administrative databases can lack pertinent detail. The purpose of our study was to use a real-time surgery-booking software program to examine surgical wait times at a single centre. METHODS: The real-time wait list management system Axcess.Rx has been used exclusively by the department of urology at the Kingston General Hospital to book all nonemergency surgery for 4 years. We reviewed the length of time from the decision to perform surgery to the actual date of surgery for patients in our group urological practice. Variables thought to be potentially important in predicting wait time were also collected, including the surgeon's assessment of urgency, the type of procedure (i.e., diagnostic, minor cancer, major cancer, minor benign, major benign), age and sex of the patient, inpatient versus outpatient status and year of surgery. Analysis was planned a priori to determine factors that affected wait time by using multivariate analysis to analyze variables that were significant in univariate analysis. RESULTS: There were 960 operations for cancer and 1654 for benign conditions performed during the evaluation period. The overall mean wait time was 36 days for cancer and 47 days for benign conditions, respectively. The mean wait time for cancer surgery reached a nadir in 2004 at 29.9 days and subsequently increased every year, reaching 56 days in 2007. In comparison, benign surgery reached a nadir wait time of 33.7 days in 2004 and in 2007 reached 74 days at our institution. Multivariate analysis revealed that the year of surgery was still a significant predictor of wait time. Urgency score, type of procedure and inpatient versus outpatient status were also predictive of wait time. CONCLUSION: The application of a prospectively collected data set is an effective and important tool to measure and subsequently examine surgical wait times. This tool has been essential to the accurate assessment of the effect of resource allocation on wait times for priority and nonpriority surgical programs within a discipline. Such tools are necessary to more fully assess and follow wait times at an institution or across a region.
Authors: Michael Jewett; Ricardo Rendon; George Dranitsaris; Darrel Drachenberg; Simon Tanguay; Bryan Donnelly; Neil Fleshner Journal: Can J Urol Date: 2006-06 Impact factor: 1.344
Authors: David Bell; Christopher Morash; George Dranitsaris; Jonathan Izawa; Thomas Short; Laurence H Klotz; Neil Fleshner Journal: Can J Urol Date: 2006-06 Impact factor: 1.344
Authors: Marie-Claire Gaudet; Debbie Ehrmann Feldman; Michel Rossignol; David Zukor; Michael Tanzer; Charles Gravel; Nicholas Newman; Réjean Dumais; Ian Shrier Journal: Can J Surg Date: 2007-04 Impact factor: 2.089
Authors: K Tran; C Sandoval; R Rahal; G Porter; R Siemens; J Hernandez; S Fung; C Louzado; J Liu; H Bryant Journal: Curr Oncol Date: 2015-10 Impact factor: 3.677
Authors: Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens Journal: Can Urol Assoc J Date: 2016-02-08 Impact factor: 1.862
Authors: Xavier Bonfill; María José Martinez-Zapata; Robin W M Vernooij; María José Sánchez; María Morales Suárez-Varela; Javier de la Cruz; José Ignacio Emparanza; Montserrat Ferrer; José Ignacio Pijoán; Juan M Ramos-Goñi; Joan Palou; Stefanie Schmidt; Víctor Abraira; Javier Zamora Journal: BMC Urol Date: 2015-07-02 Impact factor: 2.264
Authors: Xavier Bonfill; María José Martinez-Zapata; Robin W M Vernooij; María José Sánchez; María Morales Suárez-Varela; Javier De la Cruz; José Ignacio Emparanza; Montserrat Ferrer; José Ignacio Pijoan; Joan Palou; Stefanie Schmidt; Eva Madrid; Víctor Abraira; Javier Zamora Journal: BMC Res Notes Date: 2017-12-07
Authors: Weng Hong Fun; Ee Hong Tan; Sondi Sararaks; Shakirah Md Sharif; Iqbal Ab Rahim; Suhana Jawahir; Vivien Han Ying Eow; Raoul Muhammad Yusof Sibert; Malindawati Mohd Fadzil; Siti Haniza Mahmud Journal: Healthcare (Basel) Date: 2021-05-31